Overview
- 3 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-08-25.
At a glance
Inspections
3
Sites
3
Observations
0
Career since
Sep 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| GI Accelerate Memphis LLC | 25 Aug 2023 | Biologics | On file |
| ROSLIN CELL THERAPIES LIMITED | 4 Aug 2023 | Biologics | On file |
| Janssen Pharmaceuticals Inc. | 17 Sep 2021 | Biologics |
Sites inspected
GI Accelerate Memphis LLCMemphis, United States1 insp.
ROSLIN CELL THERAPIES LIMITEDEdinburgh, United Kingdom1 insp.
Janssen Pharmaceuticals Inc.Raritan, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jessica Chery2 shared
Hoda N Abadeer1 shared
Carl A Perez1 shared
Gregory A Price1 shared
Prajakta A Varadkar1 shared
Donald B Ertel1 shared
Wei Wang1 shared
Jacqueline M Diaz Albertini1 shared
David E Bailey1 shared
Lily Y Koo1 shared
Full investigator report
Get the verbatim findings behind Zhaohui Ye's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site